LaurieDeeSnyderMD
Pulmonology • Durham, NCCritical Care Medicine, Lung Transplantation Medicine, Pleural Disease
Assistant Professor, Medicine, Duke University School of Medicine
Dr. Snyder is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4101 N Roxboro St
Durham, NC 27704Phone+1 919-684-8111
Education & Training
Duke University HospitalFellowship, Pulmonary Disease and Critical Care Medicine, 2003 - 2006
University of California (San Francisco)Residency, Internal Medicine, 2000 - 2003
Duke University School of MedicineClass of 2000
Certifications & Licensure
CA State Medical License 2001 - Present
NC State Medical License 2003 - 2025
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- Lung Transplant Plasmapheresis/Belatacept/Carfilzomib for Antibody Mediated Rejection and Desensitization Start of enrollment: 2019 May 01
- Long Term Follow up of the LTOG Cohort Start of enrollment: 2021 Jun 15
Publications & Presentations
PubMed
- Predictors of Long-Term Survival in Patients with Idiopathic Pulmonary Fibrosis: Data from the IPF-PRO Registry.Hyun J Kim, Jeremy M Weber, Megan L Neely, Amy Hajari Case, Aiham H Jbeli
Lung. 2025-03-09 - Long-Term Air Pollution Exposure and Severity of Idiopathic Pulmonary Fibrosis: Data from the Idiopathic Pulmonary Fibrosis Prospective Outcomes (IPF-PRO) Registry.Coralynn Sack, Daniel M Wojdyla, Maeve G MacMurdo, Amanda Gassett, Joel D Kaufman
Annals of the American Thoracic Society. 2025-03-01 - 1 citationsIdentification and validation of a threshold for early posttransplant bronchoalveolar fluid hyaluronan that distinguishes lung recipients at risk for chronic lung allo...Jamie L Todd, Jeremy M Weber, Francine L Kelly, Andrew Nagler, Patrick McArthur
The Journal of Heart and Lung Transplantation. 2025-03-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
